El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

Acord cadru - Medicamente Program Oncologie (Antineoplazice)

Buyer: SPITALUL JUDETEAN DE URGENTA VASLUI

Published
21 October 2025
Submission deadline
21 November 2025, 15:00
Place of performance
RO216
Procedure
Open procedure
Documents
1
Notice number
00692483-2025
Reference
c4d24567-4879-4f70-bed0-a3be0a3afdd8
Official source
Official source

CPV codes

Description

Medicamente cuprinse in cadrul Programului National de Sanatate - Antineoplazice, CPV: 33652100-6 Antineoplazice (Rev.2), necesare tratamentului bolnavilor oncologici conform Programului National de Sanatate - Antineoplazice. Cantitatile necesare sunt specificate in Caietul de sarcini. Numărul de zile până la care se pot solicita clarificări înainte de data limită de depunere a ofertelor este de 18 zile. Autoritatea contractantă va răspunde în mod clar și complet tuturor solicitărilor de clarificări/informatii suplimentare in a 11-a zi inainte de data limita stabilita pentru depunerea ofertelor conform art. 161 din Legea nr. 98/2016; prevederile art. 8 alin (2) din HG nr. 419/2018. La finalizarea procedurii de achiziție publică, Autoritatea contractantă urmează să încheie un singur ACORD-CADRU cu operatorii economici clasati pe primele 3 locuri pentru o perioada de 36 luni.

Lots (12)

LotDescriptionCPV codeAmount
1 IPILIMUMABUM CONC PT SOL PERF 5MG/ML -a 40 ML
RO216
33652100 Agentes antineoplásicos
2 IPILIMUMABUM CONC PT SOL PERF 5MG/ML -a 10 ML
RO216
33652100 Agentes antineoplásicos
3 NIVOLUMABUM CONC PT SOL PERF 10MG/ML - 120 MG
RO216
33652100 Agentes antineoplásicos
4 TRASTUZUMABUM DERUXTECANUM PULB. PT. CONC. PT. SOL. PERF. - 100 MG
RO216
33652100 Agentes antineoplásicos
5 TRASTUZUMABUM EMTANSINUM PULB. PT. CONC. PT. SOL. PERF. 100 mg
RO216
33652100 Agentes antineoplásicos
6 TRASTUZUMABUM EMTANSINUM PULB. PT. CONC. PT. SOL. PERF. 160 mg
RO216
33652100 Agentes antineoplásicos
7 CABAZITAXELUM CONC PT SOL PERF 10MG/ML - a 6 ML
RO216
33652100 Agentes antineoplásicos
8 AVELUMABUM CONC. PT. SOL. PERF.20 mg/ml - a 10 ML
RO216
33652100 Agentes antineoplásicos
9 CYCLOPHOSPHAMIDUM PULB. PT. SOL. INJ. / PERF. 200 mg
RO216
33652100 Agentes antineoplásicos
10 OXALIPLATINUM CONC. PT. SOL. PERF. 5mg/ml -a 20 ML
RO216
33652100 Agentes antineoplásicos
11 GEMCITABINUM PULB. PT. SOL. PERF. 1G - 1000 MG
RO216
33652100 Agentes antineoplásicos
12 VACCIN BCG - PULB.+SOLV. PT. SUSP. INTRAVEZICALA
RO216
33650000 Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores

Award criteria

Official publications

Other tenders from SPITALUL JUDETEAN DE URGENTA VASLUI

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 21 November 2025, 15:00. Check the official source, as dates can be modified.
Who is the buyer of this tender?
The contracting authority is SPITALUL JUDETEAN DE URGENTA VASLUI (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.